Health Cor Management, L.P. Portfolio Holdings

Health Cor Management, L.P.

  • $106 Million
  • Q4 2022

Health Cor Management, L.P. has filed its 13F form on February 14, 2023 for Q4 2022 where it was disclosed a total value porftolio of $106 Million distributed in 22 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Biomarin Pharmaceutical Inc with a value of $38.1M, Dexcom Inc with a value of $36.4M, Cytokinetics Inc with a value of $7.53M, Hyperfine, Inc. with a value of $3.26M, and Alkermes Plc. with a value of $2.87M.

Examining the 13F form we can see an decrease of $694M in the current position value, from $800M to 106M.

Health Cor Management, L.P. is based out at New York, NY

Below you can find more details about Health Cor Management, L.P. portfolio as well as his latest detailed transactions.

Portfolio value $106 Million
Healthcare: $106 Million
ETFs: $2,000

Stock Holdings Table Market Cap. of $200 Billions or more

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 22
  • Current Value $106 Million
  • Prior Value $800 Million
  • Filing
  • Period Q4 2022
  • Filing Date February 14, 2023
  • Form Type 13F-HR
  • Activity in Q4 2022
  • New Purchases 6 stocks
  • Additional Purchases 2 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 11 stocks
Track This Portfolio

Track Health Cor Management, L.P. Portfolio

Follow Health Cor Management, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Health Cor Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Health Cor Management, L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email